Menaquinone 4 increases plasma lipid levels in hypercholesterolemic mice
Abstract In calcific aortic valve disease (CAVD) progressive valvular calcification causes aortic valve dysfunction. CAVD has several risk factors such as age and dyslipidemia. Vitamin K was shown to inhibit vascular calcification in mice and valvular calcification in patients with CAVD. We studied...
Guardado en:
Autores principales: | Jonna Weisell, Anna-Kaisa Ruotsalainen, Juha Näpänkangas, Matti Jauhiainen, Jaana Rysä |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ffd20781cb1240a19bd1ecf62cb905b8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
SUR1-E1506K mutation impairs glucose tolerance and promotes vulnerable atherosclerotic plaque phenotype in hypercholesterolemic mice.
por: Erika Gurzeler, et al.
Publicado: (2021) -
SUR1-E1506K mutation impairs glucose tolerance and promotes vulnerable atherosclerotic plaque phenotype in hypercholesterolemic mice
por: Erika Gurzeler, et al.
Publicado: (2021) -
Simultaneous Determination of Vitamins D3 (Calcitriol, Cholecalciferol) and K2 (Menaquinone-4 and Menaquinone-7) in Dietary Supplements by UHPLC
por: Anca Becze, et al.
Publicado: (2021) -
Effects of high rosuvastatin doses on hepatocyte mitochondria of hypercholesterolemic mice
por: Juan C. Díaz-Zagoya, et al.
Publicado: (2021) -
Scavenging of reactive dicarbonyls with 2-hydroxybenzylamine reduces atherosclerosis in hypercholesterolemic Ldlr −/− mice
por: Huan Tao, et al.
Publicado: (2020)